Cat.#: ACPP-1291
| Despition | FGFR1 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1335 | Nicotinic Acetylcholine Receptor alpha 7 Blocking Peptide (AC1335) | 250 µg | inquiry |
| ACPP-1310 | SHC Blocking Peptide (AC1310) | 250 µg | inquiry |
| ACPP-1417 | Human STMN3 Protein (AC1417) | 2 µg | inquiry |
| ACPP-1390 | Human GDF11 Protein, His (AC1390) | 5 µg | inquiry |
| ACPP-1022 | Recombinant Human Integrin beta 1 Protein (Fc Tag) (AC1022) | 50 µg | inquiry |
| ACPP-1403 | Human Insulin (Active) Protein (AC1403) | 1 mg | inquiry |
| ACPP-1289 | Usherin Blocking Peptide (AC1289) | 250 µg | inquiry |
| ACPP-1819 | Human TRH Protein (AC1819) | 100 mg | inquiry |
| ACPP-1449 | Human IL 6 Protein, CHO (AC1449) | 5 µg | inquiry |
| ACPP-1586 | Human SERPINI1 Protein (AC1586) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.